Skip to main content
Macter International Limited logo

Macter International Limited — Investor Relations & Filings

Ticker · MACTER ISIN · PK0113501016 PSX Manufacturing
Filings indexed 184 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country PK Pakistan
Listing PSX MACTER

About Macter International Limited

https://macter.com/

Macter International Limited is a prominent pharmaceutical company with over four decades of experience in the manufacturing and marketing of a diverse range of pharmaceutical, biological, and consumer products. Leveraging state-of-the-art biotech facilities, the company is recognized for its commitment to quality and affordability. Macter also serves as a leading contract manufacturer for global healthcare companies, providing essential formulations and products. Its operations are dedicated to serving patients, doctors, and the broader health community.

Recent filings

Filing Released Lang Actions
Transmission of Quarterly Report for the Period Ended March 31, 2026
Regulatory Filings
2026-04-30 English
Financial Results for the Quarter Ended March 31, 2026
Interim / Quarterly Report Classification · 100% confidence The document is titled as "Financial Results for the period ended March 31, 2026" and contains detailed financial statements including unconsolidated and consolidated condensed interim statements of profit or loss, financial position, changes in equity, and cash flows. The period covered is the quarter and nine months ended March 31, 2026, which is less than a full fiscal year. The document includes substantive financial data and analysis, not just an announcement or summary. It is not a full annual report (10-K), but rather a comprehensive interim report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2026
2026-04-27 English
Presentation of Corporate Briefing Session
Interim / Quarterly Report Classification · 95% confidence The document is a detailed presentation titled 'Corporate Briefing Session Half year FY 2025-26' for Macter International Limited. It includes comprehensive company overview, manufacturing capabilities, and detailed financial highlights including profit & loss and statement of financial position for the half year ended December 31, 2025. The presence of substantive financial data and analysis for a half-year period indicates this is a financial report for a period shorter than a full fiscal year. The document is not merely an announcement or invitation but contains actual financial statements and performance metrics. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2026
2026-03-17 English
Rescheduled Corporate Briefing Session of Macter International Limited
Regulatory Filings Classification · 95% confidence The document is a notice informing about the rescheduling of a Corporate Briefing Session (CBS) for Macter International Limited. It provides details about the new date, time, and mode of the session, and instructions for registration. There is no financial data, report content, or detailed presentation included. The document is essentially an announcement related to an investor or analyst meeting, not the meeting materials or transcript itself. Given the nature of the document as a notice about a briefing session, it aligns best with the category of Investor Presentation (IP), which covers detailed presentations for investors focusing on financials, strategy, and market position. However, since this document only announces the session and does not contain the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous regulatory announcements and notices that do not fit other categories. The document length is short (1550 characters), and it does not contain any financial statements or detailed report content, so it is not an Annual Report, Interim Report, or Earnings Release. Therefore, the best classification is Regulatory Filings (RNS).
2026-03-13 English
Postponement of Corporate Briefing Session of Macter International Limited
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about the postponement of a corporate briefing session. It does not contain any financial data, report content, or detailed presentation materials. It is an announcement related to scheduling of an investor or analyst meeting, not the meeting materials themselves. Given the brevity and nature of the content, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement without detailed financial or strategic information.
2026-03-02 English
Corporate Briefing Session of Macter International Limited
Investor Presentation Classification · 90% confidence The document is a notice informing about a scheduled Corporate Briefing Session (CBS) for Macter International Limited for the period ended December 31, 2025. It invites analysts, investors, and shareholders to register for the session, which will be held via Zoom. The document does not contain any financial data, results, or detailed report content. It is essentially an announcement of an upcoming event related to investor communication, specifically a briefing session. This fits best under the category of Investor Presentation (IP), as it is a detailed presentation for investors focusing on financials, strategy, and market position, even though the actual presentation is to be held later. The document is not a report itself, nor a regulatory filing or certification. Given the nature and content, the classification is Investor Presentation (IP) with high confidence.
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.